Abstract:By comparing mature CD8-cell turnover in different organs, we previously demonstrated that CD8 cells proliferate predominantly in the bone marrow (BM). To investigate the mechanisms underlying such increased turnover, we compared BM, lymph nodes, and spleen CD8 cells from untreated C57BL/6 mice regarding in vivo proliferation within the organ; in vitro response to interleukin-7 (IL-7), IL-15, IL-21; ex vivo expression of membrane CD127 (IL-7Ralpha), intracellular Bcl-2, phospho-STAT-5 (signal transducer and ac… Show more
“…This finding not only argues against the possibility that GITR hi and GITR lo cells are different subsets of T cells within the spleen versus bone marrow, or that IL-15 is required to maintain a unique subset of memory T cells that is resident in the bone marrow, but rather it suggests that GITR upregulation in the bone marrow reflects the local microenvironment. Our data concur with studies from Di Rosa and colleagues (21,22), which indicate that despite the lack of recent Ag exposure, bone marrow CD8 memory T cells have a more activated phenotype than do their counterparts in other organs. They also demonstrated that although homeostatic proliferation is augmented in the bone marrow, CD8 memory T cells in this organ do not have an intrinsic ability for enhanced cytokine-mediated proliferation, suggesting that they are stimulated to proliferate locally in the bone marrow (21).…”
Section: Discussionsupporting
confidence: 92%
“…Our data concur with studies from Di Rosa and colleagues (21,22), which indicate that despite the lack of recent Ag exposure, bone marrow CD8 memory T cells have a more activated phenotype than do their counterparts in other organs. They also demonstrated that although homeostatic proliferation is augmented in the bone marrow, CD8 memory T cells in this organ do not have an intrinsic ability for enhanced cytokine-mediated proliferation, suggesting that they are stimulated to proliferate locally in the bone marrow (21). This is con- hi T cells recovered from each organ was determined.…”
Section: Discussionsupporting
confidence: 92%
“…It has been previously demonstrated that T cells in the bone marrow can have a more activated phenotype than do splenic T cells (21,22). We sought to confirm this by comparing the expression of various activation markers and cytokine receptors in both organs of unimmunized mice.…”
Section: Gitr Hi Cells Resemble Cytokine-activated T Cellsmentioning
CD8 memory T cells are enriched in the bone marrow, a site where these cells are thought to receive homeostatic signals. However, the primary site where CD8 memory T cells receive their cytokine-induced homeostatic signals has recently come under debate. In this study, we demonstrate that the bone marrow contains a fraction of CD8 memory phenotype T cells with elevated expression of glucocorticoid-induced TNFR-related protein (GITR). In contrast, splenic and lymph node memory phenotype T cells have GITR levels similar to those on naive T cells. The bone marrow GITRhi memory T cells have a phenotype indicative of cytokine activation, with higher CD122 and lower CD127 than do the GITRbasal memory T cells. Remarkably, these bone marrow-specific GITRhi cells are almost completely ablated in the absence of IL-15, whereas TNFR2 and 4-1BB expression on the CD8 memory T cells are IL-15 independent. Furthermore, adoptively transferred splenic CD8 memory phenotype T cells show IL-15–dependent GITR upregulation upon entry into the bone marrow. This result implies that the selective appearance of GITRhi memory phenotype T cells in the bone marrow reflects the local microenvironment rather than a different subset of memory T cells. GITR−/− mice have a lower frequency of CD8 memory phenotype cells in the bone marrow, yet the GITR−/− cells hyperproliferate compared with those in wild-type mice. Taken together, these data suggest that GITR plays a role in the survival of CD8 memory phenotype T cells and that GITR upregulation represents a precise marker of cells that have responded to IL-15.
“…This finding not only argues against the possibility that GITR hi and GITR lo cells are different subsets of T cells within the spleen versus bone marrow, or that IL-15 is required to maintain a unique subset of memory T cells that is resident in the bone marrow, but rather it suggests that GITR upregulation in the bone marrow reflects the local microenvironment. Our data concur with studies from Di Rosa and colleagues (21,22), which indicate that despite the lack of recent Ag exposure, bone marrow CD8 memory T cells have a more activated phenotype than do their counterparts in other organs. They also demonstrated that although homeostatic proliferation is augmented in the bone marrow, CD8 memory T cells in this organ do not have an intrinsic ability for enhanced cytokine-mediated proliferation, suggesting that they are stimulated to proliferate locally in the bone marrow (21).…”
Section: Discussionsupporting
confidence: 92%
“…Our data concur with studies from Di Rosa and colleagues (21,22), which indicate that despite the lack of recent Ag exposure, bone marrow CD8 memory T cells have a more activated phenotype than do their counterparts in other organs. They also demonstrated that although homeostatic proliferation is augmented in the bone marrow, CD8 memory T cells in this organ do not have an intrinsic ability for enhanced cytokine-mediated proliferation, suggesting that they are stimulated to proliferate locally in the bone marrow (21). This is con- hi T cells recovered from each organ was determined.…”
Section: Discussionsupporting
confidence: 92%
“…It has been previously demonstrated that T cells in the bone marrow can have a more activated phenotype than do splenic T cells (21,22). We sought to confirm this by comparing the expression of various activation markers and cytokine receptors in both organs of unimmunized mice.…”
Section: Gitr Hi Cells Resemble Cytokine-activated T Cellsmentioning
CD8 memory T cells are enriched in the bone marrow, a site where these cells are thought to receive homeostatic signals. However, the primary site where CD8 memory T cells receive their cytokine-induced homeostatic signals has recently come under debate. In this study, we demonstrate that the bone marrow contains a fraction of CD8 memory phenotype T cells with elevated expression of glucocorticoid-induced TNFR-related protein (GITR). In contrast, splenic and lymph node memory phenotype T cells have GITR levels similar to those on naive T cells. The bone marrow GITRhi memory T cells have a phenotype indicative of cytokine activation, with higher CD122 and lower CD127 than do the GITRbasal memory T cells. Remarkably, these bone marrow-specific GITRhi cells are almost completely ablated in the absence of IL-15, whereas TNFR2 and 4-1BB expression on the CD8 memory T cells are IL-15 independent. Furthermore, adoptively transferred splenic CD8 memory phenotype T cells show IL-15–dependent GITR upregulation upon entry into the bone marrow. This result implies that the selective appearance of GITRhi memory phenotype T cells in the bone marrow reflects the local microenvironment rather than a different subset of memory T cells. GITR−/− mice have a lower frequency of CD8 memory phenotype cells in the bone marrow, yet the GITR−/− cells hyperproliferate compared with those in wild-type mice. Taken together, these data suggest that GITR plays a role in the survival of CD8 memory phenotype T cells and that GITR upregulation represents a precise marker of cells that have responded to IL-15.
“…We characterized some of the molecular events occurring in CD8 T cells within the BM, such as increased phosphorylation of the signal-transducing molecules STAT-5 and p38 MAPK and reduced membrane expression of CD127, the IL-7R ␣-chain (5). Both naive-phenotype CD44 int/low and memory-phenotype CD44 high CD8 T cells contain a higher percentage of proliferating cells in the BM than in spleen and LN (5). The important role played by the BM in mature CD8 T cell turnover becomes even more evident when the total numbers of proliferating CD8 T cells contained in the sum of spleen, LN, and BM are taken into account.…”
“…Of particular interest is the BM, in which a significantly increased number of these cells was found compared with WT memory T cells. It has been shown that the survival factors IL-7 and IL-15 are expressed in the BM (23,34,35). In addition, memory CD8 T cells are reported to use IL-15 in the BM to turn over (23).…”
Section: Ccr7 Ko Memory T Cells Showed Faster Homeostatic Proliferatimentioning
C-C receptor 7 (CCR7) is important to allow T cells and dendritic cells to migrate toward CCL19- and CCL21-producing cells in the T-cell zone of the spleen and lymph nodes. The role of this chemokine receptor in regulating the homeostasis of effector and memory T cells during acute viral infection is poorly defined, however. In this study, we show that CCR7 expression alters memory CD8 T-cell homeostasis following lymphocytic choriomeningitis virus infection. Greater numbers of CCR7-deficient memory T cells were formed and maintained compared with CCR7-sufficient memory T cells, especially in the lung and bone marrow. The CCR7-deficient memory T cells also displayed enhanced rates of homeostatic turnover, which may stem from increased exposure to IL-15 as a consequence of reduced exposure to IL-7, because removal of IL-15, but not of IL-7, normalized the numbers of CCR7-sufficient and CCR7-deficient memory CD8 T cells. This result suggests that IL-15 is the predominant cytokine supporting augmentation of the CCR7−/− memory CD8 T-cell pool. Taken together, these data suggest that CCR7 biases memory CD8 T cells toward IL-7–dependent niches over IL-15–dependent niches, which provides insight into the homeostatic regulation of different memory T-cell subsets.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.